Multivalent entrain-and-amplify immunotherapeutics for...

Details Multivalent entrain-and-amplify immunotherapeutics for... Multivalent entrain-and-amplify immunotherapeutics for...

2006-06-16

2011-12-27

Yu, Misook (Department: 1642)

Organic compounds -- part of the class 532-570 series

Organic compounds

Carbohydrates or derivatives

C530S328000, C514S04400A, C514S001100

Reexamination Certificate

active

08084592

ABSTRACT:
The present invention provides a method of treating a cell proliferative disease such as cancer by providing to a subject in need thereof an immunogenic composition comprising plasmid and peptide(s) or analogues thereof. In embodiments of the present invention there is provided methods and compositions for inducing, entraining, and/or amplifying the immune response to MHC class-I restricted epitopes of carcinoma antigens to generate an effective anti-cancer immune response.

REFERENCES:
patent: 5464756 (1995-11-01), Henner et al.
patent: 5538866 (1996-07-01), Israeli et al.
patent: 5620886 (1997-04-01), Brichard et al.
patent: 5683886 (1997-11-01), van der Bruggen et al.
patent: 5747271 (1998-05-01), Boon-Falleur et al.
patent: 5804381 (1998-09-01), Chen et al.
patent: 5830753 (1998-11-01), Coulie et al.
patent: 5840839 (1998-11-01), Wang et al.
patent: 5874560 (1999-02-01), Kawakami et al.
patent: 5994523 (1999-11-01), Kawakami et al.
patent: 6025191 (2000-02-01), Pfreundschuh
patent: 6709844 (2004-03-01), Levy
patent: 6861234 (2005-03-01), Simard et al.
patent: 6977074 (2005-12-01), Kundig et al.
patent: 6994851 (2006-02-01), Kundig et al.
patent: 7232682 (2007-06-01), Simard et al.
patent: 7252824 (2007-08-01), Simard et al.
patent: 2003/0138808 (2003-07-01), Simard et al.
patent: 2003/0180949 (2003-09-01), Levy
patent: 2003/0215425 (2003-11-01), Simard et al.
patent: 2003/0220239 (2003-11-01), Simard et al.
patent: 2003/0228634 (2003-12-01), Simard et al.
patent: 2004/0063120 (2004-04-01), Beer et al.
patent: 2004/0180354 (2004-09-01), Simard et al.
patent: 2004/0203051 (2004-10-01), Simard et al.
patent: 2005/0069982 (2005-03-01), Simard et al.
patent: 2005/0079152 (2005-04-01), Bot et al.
patent: 2005/0118186 (2005-06-01), Chiang et al.
patent: 2005/0130920 (2005-06-01), Simard et al.
patent: 2005/0142144 (2005-06-01), Simard et al.
patent: 2005/0221440 (2005-10-01), Simard et al.
patent: 2005/0260234 (2005-11-01), Simard et al.
patent: 2005/0287068 (2005-12-01), Bot et al.
patent: 2006/0008468 (2006-01-01), Chiang et al.
patent: 2006/0057673 (2006-03-01), Liu et al.
patent: 2006/0063913 (2006-03-01), Liu et al.
patent: 2006/0094661 (2006-05-01), Liu et al.
patent: 2006/0153844 (2006-07-01), Kundig et al.
patent: 2006/0153858 (2006-07-01), Kundig et al.
patent: 2006/0159689 (2006-07-01), Chiang et al.
patent: 2006/0159694 (2006-07-01), Chiang et al.
patent: 2006/0165711 (2006-07-01), Bot et al.
patent: 2006/0269521 (2006-11-01), Levy
patent: 2007/0004662 (2007-01-01), Qiu et al.
patent: 2007/0049533 (2007-03-01), Liu et al.
patent: 2007/0060518 (2007-03-01), Liu et al.
patent: 2007/0060524 (2007-03-01), Liu et al.
patent: 2007/0184062 (2007-08-01), Simard et al.
patent: 2007/0269464 (2007-11-01), Simard
patent: 2008/0014211 (2008-01-01), Bot et al.
patent: 739189 (1998-07-01), None
patent: 1118860 (2001-07-01), None
patent: WO 99/02183 (1999-01-01), None
patent: WO 02/081646 (2002-10-01), None
patent: WO 03/011332 (2003-02-01), None
patent: WO 2004/011483 (2004-02-01), None
patent: WO 2004/018666 (2004-03-01), None
patent: WO 2004/022709 (2004-03-01), None
patent: WO 2004/112825 (2004-12-01), None
patent: WO 2004/112825 (2004-12-01), None
patent: WO 2005/002621 (2005-01-01), None
patent: WO 2005/010190 (2005-02-01), None
patent: WO 2006/009920 (2006-01-01), None
patent: WO 2006/009920 (2006-01-01), None
patent: WO 2006/071983 (2006-07-01), None
Dorlands on-line Medical Dictionary definition of analogue, Jun. 4, 2007.
Gure, A.O. et al. 1997. “SSX: A Multigene Family with Several Members Transcribed in Normal Testis and Human Cancer.”Int. J. Cancer72: 965-971.
Pascolo et al. 1997. “HLA-A2.1-restricted Education and Cytolytic Activity of CD8+ T Lymphocytes from β2 Microglobulin (β2m) HLA-A2.1 Monochain Transgenic H-2Db β2m Double Knockout Mice.”J. Exp. Med. 185(12): 2043-2051.
U.S. Appl. No. 09/560,465, filed Apr. 28, 2000. Title: Epitope Synchronization in Antigen Presenting Cells.
U.S. Appl. No. 09/561,571, filed Apr. 28, 2000. Title: Epitope Clusters.
U.S. Appl. No. 09/561,572, filed Apr. 28, 2000. Title: Expression Vectors Encoding Epitopes of Target-Associated Antigens.
U.S. Appl. No. 09/999,186, filed Nov. 7, 2001. Title: Methods of Commercializing and Antigen.
U.S. Appl. No. 11/323,520, filed Dec. 29, 2005. Title: Methods to Bypass CD4+ Cells in the Induction of an Immune Response.
U.S. Appl. No. 11/418,397, filed May 3, 2006. Titled: Methods of Inducing a CTL Response.
U.S. Appl. No. 11/418,497, filed May 3, 2006. Title: Methods of Inducing a CTL Response.
U.S. Appl. No. 11/772,811, filed Jul. 2, 2007. Title: Anti-Neovasculature Preparations for Cancer.
U.S. Appl. No. 12/070,156, filed Feb. 15, 2008. Title: Method for Enhancing T Cell Response.
U.S. Appl. No. 60/282,211, filed Apr. 6, 2001. Title: Epitope Sequences.
U.S. Appl. No. 60/337,017, filed Nov. 7, 2001. Title: Epitope Sequences.
U.S. Appl. No. 60/580,969, filed Jun. 17, 2004. Title: Combinations of Tumor-Associated Antigens in Diagnotistics for Various Types of Cancers.
U.S. Appl. No. 60/691,581, filed Jun. 17, 2005. Title: Multivalent Entrain- and-Amplify Immunotherapeutics for Carcinoma.
Bot, A., “Potent Immunity Achieved by Targeted Sequential Administration of Recombinant DN Vectors and Anchor-Modified Epitope Peptides,” (Nov. 13, 2005) www.isbtc.org/meetings/am05/presentations/bot.pdf (retrieved 2006).
International Search Report and Written Opinion of the International Searching Authority dated Mar. 2, 2007 from International Application No. PCT/US2006/023499.
Issekutz et al., “Kinetics of cytotoxic lymphocytes in efferent lymph from single lymph nodes following immunization with vaccinia virus,” Clin Exp Immunol 56: 515-523, 1984.
Lu, J. et al., “Multiepitope Trojan Antigen Peptide Vaccines for the Induction of Antitumor CTL and Th Immune Responses,” J. Immunol., 172:4575-4582, 2004.
Spankuch-Schmitt, et al., “Downregulation of human polo-like kinase activity by antisense oligonucleotides induces growth inhibition in cancer cells,” Oncogene. 21(20):3162-3171, 2002.
Zhong L, et al., “Recombinant adenovirus is an efficient and non-perturbing genetic vector for human dendritic cells,” Eur J Immunol. 29(3):964-972, 1999.

Affiliated with

Also associated with

Rating

Multivalent entrain-and-amplify immunotherapeutics for... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Multivalent entrain-and-amplify immunotherapeutics for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Multivalent entrain-and-amplify immunotherapeutics for... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4267575